Back to calendar
Inhibikase Therapeutics, Inc. (IKT) Earnings
IKT reports earnings on Monday, November 16, 2026
earnings report
November 16, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.11
Actual EPS: $-0.11
EPS surprise: -2.33%
Company overview
Market Cap$216.3M
PriceUSD 1.55
EPS (TTM)-0.44
52-week high2.61
52-week low1.33
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees35